MeCRU Research Unit (MeCRU), at SMU has been officially launched as the research site for Phase III Paediatric COVID-19 Vaccine study conducted by the Numolux Group and Sinovac on 10 September 2021. The very first child and the second one had the honor to receive their jabs which kick started the study.
SMU bridges traditional leadership and academic excellence
Sefako Makgatho Health Sciences University (SMU) is strengthening the relationship between traditional leadership, academic research, and community development by appointing Kgosana Dr Koketso Rakhudu Goodwill as a Research Associate in the Department of Public...
